With its unique multi-targeted T cell-based immunotherapies that simultaneously attack tumors and trigger a broad spectrum antitumor immune response, Marker has generated promising clinical data ...
The tissue adjacent to a tumor behaves differently than areas farther away: The tumor's cancerous cells influence their surroundings, blocking the body's immune defenses and creating a sort of haven ...
which could achieve enhanced antitumor immune responses with a favorable biosafety profile," said Assoc. Prof. Zhao Ruifang from NCNST and the first author of this study. "However, for its ...